NLRP3 and acute respiratory distress syndrome: The present work revealed that plasma exosomes stimulated alveolar macrophages to activate the NLRP3 inflammasome, released IL-1β and induced pyroptosis, suggesting that the plasma exosome-mediated NLRP3 pathway is a potential therapeutic target for the treatment of ALI during AP (Figure 3).